← Leaderboards
Eric Jessen Chow
Fred Hutchinson Cancer Center
$11,476,004
Attributed
$13,278,883
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,278,883 · 9
By mechanism
R01$10,144,267 · 3
P30$1,311,925 · 2
R21$894,036 · 2
K07$755,295 · 1
R03$173,360 · 1
Top collaborators
- Steven Edward Lipshultz5 shared
- Patrick M Boyle2 shared
- Lindsay Atherton Edwards2 shared
- Rachel M. Ceballos1 shared
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Ajay Gopal$4,782,402
- Damian J. Green$13,222,447
- Lindsay Atherton Edwards$147,165
Others in their field
Top investigators on “Cancer Survivor”
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$129,608,255
- Laurence H Baker · University Of Michigan At Ann Arbor$81,806,892
- Peter C Adamson · National Childhood Cancer Foundation$64,769,411
- Gregory Armstrong · St. Jude Children'S Research Hospital$61,807,544
- Deborah W Bruner · American College Of Radiology$57,352,409
- Charles A Coltman · Southwest Oncology Group$46,831,444
Research focus
Cancer SurvivorParticipantMorbidity - Disease RateResourcesSurvivorsFutureCohortFollow-UpHeart FailureCancer TherapyCardiovascular DiseasesMalignant NeoplasmsRisk FactorsGeneral PopulationSurvivorshipCardiovascular SystemLife StyleChildCardiotoxicityPrematureResponseChildhood Cancer SurvivorDesignDiagnosis
Grant awards (35)
SALSA - Study of Active Lifestyle Activation$703,031
R01 · FY2025 · CA · contact PI
Prevention Center Shared Resource$256,840
P30 · FY2025 · CA · contact PI
SALSA - Study of Active Lifestyle Activation$704,363
R01 · FY2024 · CA · contact PI
Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer Survivors$214,010
R21 · FY2024 · CA · contact PI
Shared Resource: Prevention Center$213,741
P30 · FY2024 · CA · contact PI
SALSA - Study of Active Lifestyle Activation$704,529
R01 · FY2023 · CA · contact PI
Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer Survivors$227,486
R21 · FY2023 · CA · contact PI
Shared Resource: Prevention Center$213,742
P30 · FY2023 · CA · contact PI
SALSA - Study of Active Lifestyle Activation$199,496
R01 · FY2023 · CA · contact PI
SALSA - Study of Active Lifestyle Activation$697,143
R01 · FY2022 · CA · contact PI
Shared Resource: Prevention Center$213,742
P30 · FY2022 · CA · contact PI
SALSA - Study of Active Lifestyle Activation$518,969
R01 · FY2021 · CA · contact PI
Improving treatment of cardiovascular risk factors in childhood cancer survivors$487,899
R01 · FY2021 · CA · contact PI
Improving cancer survivorship care delivery in Latino survivors: telehealth & lay health educators$315,575
R21 · FY2021 · CA · contact PI
Improving treatment of cardiovascular risk factors in childhood cancer survivors$241,294
R01 · FY2021 · CA · contact PI
SALSA - Study of Active Lifestyle Activation$217,015
R01 · FY2021 · CA · contact PI
Shared Resource: Prevention Center$201,426
P30 · FY2021 · CA · contact PI
Improving cancer survivorship care delivery in Latino survivors: telehealth & lay health educators$136,965
R21 · FY2021 · CA · contact PI
Improving treatment of cardiovascular risk factors in childhood cancer survivors$740,451
R01 · FY2020 · CA · contact PI
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy$455,562
R01 · FY2020 · CA · contact PI
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy$229,522
R01 · FY2020 · CA · contact PI
Shared Resource: Prevention Center$212,434
P30 · FY2020 · CA · contact PI
Improving treatment of cardiovascular risk factors in childhood cancer survivors$720,837
R01 · FY2019 · CA · contact PI
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy$627,308
R01 · FY2019 · CA · contact PI
Improving treatment of cardiovascular risk factors in childhood cancer survivors$734,545
R01 · FY2018 · CA · contact PI
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy$646,503
R01 · FY2018 · CA · contact PI
Improving treatment of cardiovascular risk factors in childhood cancer survivors$773,174
R01 · FY2017 · CA · contact PI
Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy$742,626
R01 · FY2017 · CA · contact PI
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce$151,059
K07 · FY2015 · CA · contact PI
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce$151,059
K07 · FY2014 · CA · contact PI
Analysis of Morbidity and Mortality Among Hematopoietic Cell Transplantation Surv$85,360
R03 · FY2014 · CA · contact PI
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce$151,059
K07 · FY2013 · CA · contact PI
Analysis of Morbidity and Mortality Among Hematopoietic Cell Transplantation Surv$88,000
R03 · FY2013 · CA · contact PI
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce$151,059
K07 · FY2012 · CA · contact PI
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce$151,059
K07 · FY2011 · CA · contact PI